Evidence is continuing to accumulate on the burden and frequency of chronic effects after a COVID infection, which falls under the umbrella term "long COVID".
6 hours ago
0
0
A study of more than 50 babies in Africa, Asia, North America and South America has added substantially to evidence that giving antiretroviral therapy (ART) to newborns with HIV within the first days—rather than within ...
7 hours ago
0
1
Just over 40 years ago, the first case of acquired immunodeficiency syndrome—more commonly known as AIDS—was reported, setting into motion a worldwide panic about the unknown, devastating disease. At the time, AIDS was ...
Dec 1, 2023
0
0
Antimicrobial resistance is one of the biggest global threats to health, food security and development. This month, The Conversation's experts explore how we got here and the potential solutions.
Nov 24, 2023
0
0
Hepatitis B virus (HBV) is a significant public health problem, with over 296 million people chronically infected worldwide. Despite the availability of a safe and effective vaccine for over 40 years, HBV remains a leading ...
Nov 13, 2023
0
0
Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a new study reports an underuse of the treatment.
Nov 13, 2023
0
0
New research combining computer modeling and experiments with macaques shows the body's immune system helps control human immunodeficiency virus (HIV) infections largely by suppressing viral production in already infected ...
Nov 1, 2023
0
22
Mosquito-transmitted virus infections are on the rise and their spread is accelerating in Texas, Florida and elsewhere in the American South. With the rise of mosquito-borne illnesses, infectious disease experts at Baylor ...
Oct 17, 2023
0
15
Antiviral drugs are generally considered to be a 20th century invention. But recent research has uncovered an unexpected facet to your immune system: It can synthesize its own antiviral molecules in response to viral infections.
Oct 11, 2023
0
1
Norwegian researchers have previously demonstrated an association between diabetes and virus infection. New research shows that, among children with newly diagnosed type 1 diabetes (T1D), treatment with antiviral drugs could ...
Oct 4, 2023
0
20
Antiviral drugs are a class of medication used specifically for treating viral infections. Like antibiotics for bacteria, specific antivirals are used for specific viruses. Unlike antibiotics, antiviral drugs do not destroy their target pathogen but inhibit their development.
Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotic, antifungal and antiparasitic drugs. They are relatively harmless to the host, and therefore can be used to treat infections. They should be distinguished from viricides, which are not medication but destroy virus particles outside the body.
Most of the antivirals now available are designed to help deal with HIV, herpes viruses (best known for causing cold sores and genital herpes, but actually causing a wide range of diseases), the hepatitis B and C viruses, which can cause liver cancer, and influenza A and B viruses. Researchers are working to extend the range of antivirals to other families of pathogens.
Designing safe and effective antiviral drugs is difficult, because viruses use the host's cells to replicate. This makes it difficult to find targets for the drug that would interfere with the virus without harming the host organism's cells.
The emergence of antivirals is the product of a greatly expanded knowledge of the genetic and molecular function of organisms, allowing biomedical researchers to understand the structure and function of viruses, major advances in the techniques for finding new drugs, and the intense pressure placed on the medical profession to deal with the human immunodeficiency virus (HIV), the cause of the deadly acquired immunodeficiency syndrome (AIDS) pandemic.
Almost all anti-microbials, including anti-virals, are subject to drug resistance as the pathogens mutate over time, becoming less susceptible to the treatment. For instance, a recent study published in Nature Biotechnology emphasized the urgent need for augmentation of oseltamivir (Tamiflu) stockpiles with additional antiviral drugs including zanamivir (Relenza) based on an evaluation of the performance of these drugs in the scenario that the 2009 H1N1 'Swine Flu' neuraminidase (NA) were to acquire the tamiflu-resistance (His274Tyr) mutation which is currently wide-spread in seasonal H1N1 strains.
This text uses material from Wikipedia, licensed under CC BY-SA
